Lebanon vs Switzerland: The number of people with susceptibility test result for rifampicin
Lebanon
228
in 2021
Switzerland
220
in 2021
Lebanon rank
91st
Switzerland rank
92nd
The number of people with susceptibility test result for rifampicin over time
- Lebanon
- Switzerland
How they compare
Lebanon currently reports 228 against 220 in Switzerland, a difference of 8.
Across all 5 years both countries report, Lebanon has been ahead every year.
Lebanon ranks 91st and Switzerland ranks 92nd of 155 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 331.33 | 240.33 | 91 | Lebanon |
| 2020s | 277.5 | 195.5 | 82 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lebanon or Switzerland?
- Lebanon, at 228 against 220 in Switzerland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lebanon and Switzerland?
- 8, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Switzerland?
- 5 years are reported by both, from 2017 to 2021.
- How do Lebanon and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
- Lebanon ranks 91st and Switzerland ranks 92nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.